Chemoinformaics analysis of 2-Methyl-1,10-phenanthroline
| Molecular Weight | 194.237 | nRot | 0 |
| Heavy Atom Molecular Weight | 184.157 | nRig | 16 |
| Exact Molecular Weight | 194.084 | nRing | 3 |
| Solubility: LogS | -1.909 | nHRing | 2 |
| Solubility: LogP | 2.257 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 16 |
| nHA | 2 | APOL | 30.5779 |
| nHD | 0 | BPOL | 12.3121 |
| QED | 0.514 |
| Synth | 1.919 |
| Natural Product Likeliness | -0.917 |
| NR-PPAR-gamma | 0.96 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.021 |
| Pgp-sub | 0.038 |
| HIA | 0.004 |
| CACO-2 | -4.67 |
| MDCK | 0.0000259 |
| BBB | 0.9 |
| PPB | 0.949416 |
| VDSS | 1.405 |
| FU | 0.0436402 |
| CYP1A2-inh | 0.981 |
| CYP1A2-sub | 0.916 |
| CYP2c19-inh | 0.482 |
| CYP2c19-sub | 0.513 |
| CYP2c9-inh | 0.142 |
| CYP2c9-sub | 0.703 |
| CYP2d6-inh | 0.301 |
| CYP2d6-sub | 0.828 |
| CYP3a4-inh | 0.228 |
| CYP3a4-sub | 0.251 |
| CL | 3.83 |
| T12 | 0.345 |
| hERG | 0.037 |
| Ames | 0.875 |
| ROA | 0.241 |
| SkinSen | 0.794 |
| Carcinogencity | 0.628 |
| EI | 0.958 |
| Respiratory | 0.771 |
| NR-Aromatase | 0.132 |
| Antiviral | Yes |
| Prediction | 0.669794 |